Anti-inflammatory effects of Retama monosperma in acute ulcerative colitis in rats

Journal of Physiology and Biochemistry

Volumn 70, Issue 1, 2014, Pages 163-172

  González Mauraza, Haidee ^a   Martín Cordero, Carmen ^a   Alarcón De La Lastra, Catalina ^a   Rosillo, M Angeles ^a   León González, Antonio J ^a   Sánchez Hidalgo, Marina ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Flavonoids; Inflammation; NF B; Retama monosperma; TNBS; Ulcerative colitis

Indexed keywords

ANTIINFLAMMATORY AGENT; APIGENIN; CYCLOOXYGENASE 2; DAIDZEIN; DAIDZIN; GENISTEIN; GENISTIN; I KAPPA B; I KAPPA B ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; LUTEOLIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PLANT EXTRACT; RETAMA MONOSPERMA EXTRACT; RUTOSIDE; STRESS ACTIVATED PROTEIN KINASE; TRINITROBENZENESULFONIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; COLON MUCOSA; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; EOSINOPHIL; FABACEAE; GOBLET CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; IN VIVO STUDY; INFLAMMATORY CELL; INTESTINE INJURY; LEUKOCYTE; LYMPHOCYTE; MALE; MUCUS SECRETION; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; POLYMORPHONUCLEAR CELL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RAT; RETAMA MONOSPERMA; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; ULCERATIVE COLITIS;

ACUTE DISEASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; COLITIS, ULCERATIVE; COLON; CYCLOOXYGENASE 2; DRUG EVALUATION, PRECLINICAL; ETHANOL; FABACEAE; GENE EXPRESSION; I-KAPPA B PROTEINS; MALE; MAP KINASE SIGNALING SYSTEM; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; PLANT EXTRACTS; RATS; RATS, WISTAR; TRINITROBENZENESULFONIC ACID;

EID: 84896327607     PISSN: 11387548     EISSN: 18778755     Source Type: Journal    
DOI: 10.1007/s13105-013-0290-3     Document Type: Article

References (31)

1. Belmokhtar Z, Kaid-Harche M (2012) Evaluation of genetic diversity in three species of Retama genus: R. monosperma (L) Boiss, R. raetam (Forssk) Webb and R. sphaerocarpa (L) Boiss. (Fabaceae) based on SDS-PAGE. Curr Res J Biol Sci 4:202-205
2. Benitez Cruz G (2007) El uso de las plantas a través de la cultura tradicional Lojeña. Fundación Ibn al-Jatib de Estudios de Cooperación. Granada, Cultural
3. Bobin-Dubigeon C, Collin X, Grimaud N, Robert JM, Le Baut G, Petit JY (2001) Effects of tumour necrosis factor-alpha synthesis inhibitors on rat trinitrobenzene sulphonic acid-induced chronic colitis. Eur J Pharmacol 9:103-110
4. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 7:248-254
5. Bremner P, Rivera D, Calzado MA, Obón C, Inocencio C, Beckwith C, Fiebich BL, Muñoz E, Heinrich M (2009) Assessing medicinal plants from South-Eastern Spain for potential anti-inflammatory effects targeting nuclear factor-Kappa B and other pro-inflammatory mediators. J Ethnopharmacol 115:295-305
6. Brenna O, Furnes MW, Drozdov I, Van Beelen Granlund A, Flatberg A, Sandvik AK, Zwiggelaar RT, Mårvik R, Nordrum IS, Kidd M, Gustafsson BI (2013) Relevance of TNBS-Colitis in rats: a methodological study with endoscopic, historical and transcriptomic characterization and correlation to IBD. PLoS One 8:e54543
7. Coskun ZK, Kerem M, Gurbuz N, Omeroglu S, Pasaoglu H, Demirtas C, Lortlar N, Salman B, Pasaoglu OT, Turgut HB (2011) The study of biochemical and histopathological effects of spirulina in rats with TNBS-induced colitis. Bratisl Med J 112:235-243
8. Cruz T, Galvez J, Ocete MA, Crespo ME, Sanchez de Medina F, Zarzuelo A (1998) Oral administration of rutoside can ameliorate inflammatory bowel disease in rats. Life Sci 62:687-695
9. Danese S, Fiocchi C (2006) Etiopathogenesis of inflammatory bowel diseases. World J Gastroenterol 14:4807-4812
10. Dong C, Davis RJ, Flavell RA (2002) MAP kinases in the immune response. Annu Rev Immunol 20:55-72
11. El-Toumy SA, Farrag AH, Ellithey MM, Korien KM (2011) Effect of plant derived-phenolic extracts on antioxidant enzyme activity and mucosal damage caused by indomethacin in rats. J Pharm Res 4:189-192
12. El-Shazly A, Ateya, AM, Witte L, Wink M. 1996. Quinolizidine alkaloid profiles of Retama raetam, R. sphaerocarpa and R. monosperma. Z. Naturforsch 51c: 301-308.
13. Feng YJ, Li YY (2011) The role of p38 mitogen-activated protein kinase in the pathogenesis of inflammatory bowel disease. J Dig Dis 12:327-332
14. Grisham MB, Benoit JN, Granger DN (1990) Assessment of leukocyte involvement during ischemia and reperfusion of intestine. Methods Enzymol 186:729-742
15. Hommes D, van den Blink B, Plasse T, Bartelsman J, Xu C, Macpherson B, Tytgat G, Peppelenbosch M, Van Deventer S (2002) Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease. Gastroenterology 122:7-14
16. EGFP transgenic mice through blockade of NF-κB-dependent protective molecules. PLoS ONE 2:e596
17. Kwon KH, Murakami A, Tanaka T, Ohigashi H (2005) Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression. Biochem Pharmacol 69:395-406
18. Li J, Li Z, Mo BQ (2006) Effects of ERK5 MAPK signaling transduction pathway on the inhibition of genistein to breast cancer cells. J Hyg Res 35:184-186
19. López-Lázaro M, Martín-Cordero C, Ayuso MJ (1999) Flavonoids of Retama sphaerocarpa. Planta Med 65:777-778
20. Makkink MK, Schwerbrock NM, Mähler M, Boshuizen JA, Renes IB, Cornberg M, Hedrich HJ, Einerhand AW, Büller HA, Wagner S, Enss ML, Dekker J (2002) Fate of goblet cells in experimental colitis. Dig Dis Sci 47:2286-2297
21. Neuman MG (2007) Immune dysfunction in inflammatory bowel disease. Transl Res 149:173-186
22. Nishitani Y, Yamamoto K, Yoshida M, Azuma T, Kanazawa K, Hashimoto T, Mizuno M (2013) Intestinal anti-inflammatory activity of luteolin: Role of the aglycone in NF-κB inactivation in macrophages co-cultured with intestinal epithelial cells. Biofactors. doi: 10.1002/biof.1091
23. O'Connor PM, Lapointe TK, Beck PL, Buret AG (2010) Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel disease. Inflamm Bowel Dis 16:1411-1420
24. O'Connor WJ, Zenewicz LA, Flavell RA (2010) The dual nature of T(H)17 cells: shifting the focus to function. Nat Immunol 11:471-476
25. Rosillo MA, Sanchez-Hidalgo M, Cárdeno A (2011) Protective effect of ellagic acid, a natural polyphenolic compound, in a murine model of Crohn's disease. Biochem Pharmacol 82:737-745
26. Sánchez-Hidalgo M, Martín AR, Villegas I, Alarcón De La Lastra C (2007) Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats. Eur J Pharmacol 562:247-258
27. Seibel J, Molzberger AF, Hertrampf T, Laudenbach-Leschowski U, Diel P (2009) Oral treatment with genistein reduces the expression of molecular and biochemical markers of inflammation in a rat model of chronic TNBS-induced colitis. Eur J Nutr 48:213-220
28. Wullaert A, Bonnet MC, Pasparakis M (2011) NF-κB in the regulation of epithelial homeostasis and inflammation. Cell Res 21:146-158
29. Xagorari A, Papapetropoulos A, Mauromatis A, Economou M, Fotsis T, Roussos C (2001) Luteolin inhibits an endotoxin stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages. J Pharmacol Exp Ther 296:181-187
30. Xu L, Zhang L, Bertucci AM, Pope RM, Datta SK (2008) Apigenin, a dietary flavonoid, sensitizes human T cells for activation-induced cell death by inhibiting PKB/Akt and NF-kappaB activation pathway. Immunol Lett 121:74-83
31. Yamada T, Grisham MB (1991) Role of neutrophil-derived oxidants in the pathogenesis of intestinal inflammation. Klin Wochensch 69:988-994